AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 23 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $871,438 | -35.5% | 3,004,959 | 0.0% | 0.43% | -13.8% |
| Q4 2022 | $1,351,931 | -45.0% | 3,004,959 | -35.6% | 0.50% | -35.9% |
| Q3 2022 | $2,456,000 | +4.2% | 4,668,536 | 0.0% | 0.78% | -12.0% |
| Q2 2022 | $2,358,000 | +17.7% | 4,668,536 | +435.9% | 0.89% | +33.6% |
| Q1 2022 | $2,004,000 | -15.4% | 871,101 | +74.7% | 0.66% | -7.1% |
| Q4 2021 | $2,368,000 | -33.2% | 498,500 | +11.8% | 0.71% | -36.8% |
| Q3 2021 | $3,546,000 | +26.6% | 446,000 | +10.8% | 1.13% | +62.1% |
| Q2 2021 | $2,802,000 | -12.1% | 402,653 | 0.0% | 0.70% | +7.7% |
| Q1 2021 | $3,189,000 | +112.0% | 402,653 | +110.7% | 0.65% | +110.1% |
| Q4 2020 | $1,504,000 | +0.5% | 191,104 | -9.5% | 0.31% | +4.1% |
| Q3 2020 | $1,497,000 | -23.3% | 211,104 | 0.0% | 0.30% | -48.1% |
| Q2 2020 | $1,953,000 | +205.6% | 211,104 | +62.9% | 0.57% | +71.7% |
| Q3 2017 | $639,000 | +28.1% | 129,583 | 0.0% | 0.33% | +40.1% |
| Q2 2017 | $499,000 | -60.6% | 129,583 | -23.7% | 0.24% | -66.5% |
| Q1 2017 | $1,266,000 | +54.4% | 169,889 | -9.9% | 0.71% | +48.1% |
| Q4 2016 | $820,000 | -17.1% | 188,485 | +22.1% | 0.48% | -29.9% |
| Q3 2016 | $989,000 | +43.3% | 154,332 | +8.8% | 0.68% | +93.8% |
| Q2 2016 | $690,000 | – | 141,874 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
| Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
| Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
| Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
| Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
| Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
| Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
| Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
| Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
| Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |